Evaluating the Use and Efficacy of Avonex and Plegridy in Pediatric Patients (P11-6.005)

Bradley Barney,Skyler Peterson,Michael Waltz,Melissa Wright,John Rose,Mary Rensel,Aaron Abrams,Emmanuelle Waubant,Yolanda Wheeler,Moses Rodriguez,Jan-Mendelt Tillema,Lauren Krupp,Mark Gorman,Leslie Benson,Timothy Lotze,Nikita Shukla,Soe Mar,Tanuja Chitnis,Teri Schreiner,Megan Vignos, Jonathan Planton,Theron Casper

Neurology（2024）

Cited 0|Views30
No score
Abstract
Summarize the demographic/clinical characteristics and efficacy outcomes of individuals with pediatric-onset multiple sclerosis (POMS) who were treated with Avonex or Plegridy
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined